NIW for Industry Research Scientists: Turning Company Research Into a National Interest Case
WeGreened · https://www.wegreened.com/insights/niw-for-industry-research-scientists
Research scientists at companies, from pharmaceutical and biotech firms to AI labs, semiconductor makers, and energy companies, can self-petition for a National Interest Waiver (NIW) without their employer's sponsorship. The challenge is showing that research done for a company serves the nation, not only the company's bottom line. When the petition makes that connection with evidence, industry scientists build some of the strongest NIW cases we file.
This guide explains how, based on our experience with more than 70,000 approved cases.
EB-2 Eligibility
Most industry research scientists hold a PhD, which meets the advanced degree requirement. A master's degree, or a bachelor's degree plus five years of progressive experience, also qualifies. Foreign degrees need a credential evaluation.
The Three NIW Factors
The USCIS Policy Manual requires the petitioner to establish that the proposed endeavor has substantial merit and national importance (Prong 1), that the petitioner is well positioned to advance it (Prong 2), and that on balance a waiver of the job offer and labor certification benefits the United States (Prong 3).
Prong 1: Frame the Endeavor Beyond the Company
Commercial work can have national importance. A new cancer therapy, a more efficient battery chemistry, or a safer AI system matters to the country whether a university or a company develops it. The endeavor should:
- Describe the scientific or technical problem and its significance for health, the economy, security, energy, or another national interest.
- Explain the prospective impact if the work succeeds, such as patients treated, costs reduced, or capabilities gained by U.S. industry.
- Avoid reading as a job description for one employer. The endeavor is the petitioner's line of research, which would continue at another company.
Government reports, federal funding programs, and the Policy Manual's discussion of critical and emerging technologies can support national importance for many industry fields.
Prong 2: Show Results, Not Just Credentials
Industry scientists often publish less than academics, but they produce other strong evidence:
- Patents and patent applications naming the petitioner as an inventor.
- Products, platforms, and pipelines the petitioner's research enabled, such as a drug candidate entering trials or a model deployed at scale.
- Publications and conference papers, including earlier academic work and its independent citations.
- Recognition outside the company, such as peer review for journals and conferences, invited talks, standards committee roles, and industry awards judged by independent experts.
- Letters from supervisors and colleagues with first-hand knowledge of the petitioner's specific contributions, and from independent experts outside the company. Both kinds matter equally.
In our experience, petitions from industry PhDs with a strong independent citation record are especially resilient. When the citation record is moderate, documented industry results and independent letters must carry more of the weight.
Handling Confidential Work
Nondisclosure agreements are a fact of industry research, but they do not excuse a lack of evidence. Use what can be shared: patents, publications, public announcements, regulatory filings, and redacted documents the employer approves. A detailed employer letter can confirm the petitioner's role and results without revealing trade secrets.
Prong 3: The Waiver Balance
Address the factors in the Policy Manual, including whether labor certification is impractical for the work, whether the United States would benefit even if qualified U.S. workers are available, and the urgency of the national interest. For industry scientists, explain why the value of the research lies in the petitioner's specific expertise, which serves the national interest wherever the petitioner works.
EB-1B Through a Company
A private employer can also file an EB-1B outstanding researcher petition if it employs at least three full-time researchers and has documented accomplishments in the field. The scientist needs at least three years of research experience, international recognition, and a permanent research position. EB-1B can offer a shorter wait for applicants born in countries with long EB-2 backlogs, and many industry scientists file both.
Recent Success Stories From Our Industry Scientist Clients
These recent approvals show industry scientists with very different records winning NIW approval, including one approved after an RFE. Names, companies, and institutions are withheld to protect our clients' privacy.
Industry scientist with moderate credentials in cancer bioinformatics, born in China: approved without an RFE. The client held a PhD and worked as a scientist at a U.S. company, continuing in the same role. The record was modest: 3 publications and 31 citations, with the most recent paper from 2024. Premium processing was requested at filing, and the petition was approved on November 12, 2026. The case shows that an industry scientist does not need a long publication list to qualify.
Member of technical staff in medical imaging AI, born in Taiwan: approved without an RFE. The client held a PhD and worked as a member of technical staff at a U.S. technology company, applying machine learning and computer vision to medical imaging and public health. The record was exceptional: 18 publications and 4,239 citations, with the most recent paper from 2023. Premium processing was requested at filing, and the petition was approved on November 4, 2026.
Approved through exceptional ability, without a master's degree: PhD student moving to a senior scientist role in porous materials, born in China, approved without an RFE. The client was finishing a PhD and planned to work as a senior scientist at a U.S. company. Without a conferred advanced degree, the petition established EB-2 eligibility through exceptional ability. The record included 16 publications, 155 citations, and a 2025 paper. The petition was upgraded to premium processing and approved on November 7, 2026.
Pharmacometrics scientist abroad, born in Argentina: approved after an RFE. The client held a PhD, lived in Argentina, and planned to join a U.S. company as an associate director of pharmacometrics. The NIW petition presented a record of 18 publications, 264 citations, and a 2025 paper. USCIS issued a Request for Evidence, our response added new supporting letters, and the petition was approved on November 7, 2026 under premium processing.
How We Can Help
Our attorneys prepare NIW, EB-1A, EB-1B, and O-1 petitions for industry research scientists in biotech, pharmaceuticals, AI, semiconductors, energy, and many other fields. Cases can be prepared and filed quickly, with premium processing available. To see where your record stands, request a free evaluation.
No guarantee of results: Past outcomes do not guarantee a similar result in any other case. Each petition is decided on its own record by the adjudicating officer.



